The Medical Devices sector report, “Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Auto-Immune Diseases pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Auto-Immune Diseases Diagnostic Tests are used for detection of autoimmune disorder by identifying auto-antibodies in the patient’s test sample.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Auto-Immune Diseases Diagnostic Tests are used for detection of autoimmune disorder by identifying auto-antibodies in the patient’s test sample.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Cardiovascular Monitoring Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cardiovascular Monitoring Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Cardiovascular Monitoring Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Auto-Immune Diseases - Pipeline Products under Development by Companies
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aarhus University
- Abreos Biosciences Inc
- Adaptive Biotechnologies Corp
- Albert Ludwigs University of Freiburg
- Alere Inc
- Amarantus Diagnostics Inc
- apDia nv
- Asylia Diagnostics BV
- Autoimmune Technologies LLC
- Avotres Inc
- Beckman Coulter Inc
- Bellvitge Biomedical Research Institute
- BG Medicine Inc
- Biogen Inc
- BIOHOPE Scientific SL
- Biomedal SL
- Bionure Farma SL (Inactive)
- BioShai Ltd
- Biotome Pty Ltd
- CDI Laboratories Inc
- Celdara Medical LLC
- Charite University Hospital of Berlin
- Chronix Biomedical Inc
- Cincinnati Children's Hospital Medical Center
- Cizzle Biotechnology Holdings Plc
- Co-Diagnostics Inc
- Columbia University
- Crescendo Bioscience Inc
- Department of Biomedical Engineering Columbia University
- Digna Biotech SL
- DNAlytics SA
- Enterome Bioscience SA
- Exagen Diagnostics Inc
- Exodus Biosciences LLC
- Ezose Sciences Inc.
- Flamentera AG
- Genalyte Inc
- GeNeuro SA
- Grifols SA
- Guangzhou Wondfo Biotech Co Ltd
- Hannover Medical School
- HealthTell Inc
- Helmholtz Centre for Infection Research
- HOB Biotech Group Suzhou Co Ltd
- Hospital for Special Surgery
- HTG Molecular Diagnostics Inc
- Hycor Biomedical Inc
- Ignyta Inc
- Immunarray Pvt Ltd
- Immunovia AB
- ImmusanT Inc
- Innobiochips
- Inova Diagnostics Inc
- InterVenn BioSciences
- Iron Horse Diagnostics, Inc.
- JJP Biologics Sp Zoo
- Johns Hopkins University
- Lankenau Institute for Medical Research
- LineaGen Inc
- Lophius Biosciences GmbH
- Louisville Bioscience Inc (Inactive)
- Max Delbruck Center for Molecular Medicine
- Mayo Clinic
- Medica Corp
- Medical & Biological Laboratories Co Ltd
- Metabiomics Corporation
- Metabolomic Technologies Inc
- Metabolon Inc
- Metanomics Health GmbH
- MSDx Inc
- Myriad Genetics Inc
- Nanosphere Inc (Inactive)
- Neuro Vigor LLC
- NoToPharm srl
- Numares AG
- OmniBiome Therapeutics Inc
- One Way Liver SL
- OPKO Health Inc
- Op-T-Mune Inc
- Oxford Biodynamics Plc
- Oxford Gene Technology Ltd
- Oxford Immunotec Ltd
- Pearsanta Inc
- Pediatric Bioscience LLC
- Penn State College of Medicine
- Prediction BioSciences SAS
- Progentec Diagnostics Inc
- Prometheus Biosciences Inc
- Protagen AG
- ProteinLogic Ltd
- Psyros Diagnostics Ltd
- Quanterix Corp
- Rambam Health Care Campus
- Rappaport Family Institute for Research in the Medical Science
- Revvity Inc
- Roche Diagnostics
- Roche Diagnostics International Ltd
- Royal College of Surgeons Ireland
- Scailyte AG
- Seattle Children's Hospital
- Sengenics Corp LLC
- Sequenom Inc
- Shuwen Biotech Co Ltd
- SomaLogic Inc
- Southern Illinois University Carbondale
- Spanish National Research Council
- SQI Diagnostics Inc
- Statens Serum Institut
- Sugentech Inc
- Svar Life Science AB
- TBG Diagnostics Ltd
- Tel Aviv University
- The Chinese University of Hong Kong
- The Walter and Eliza Hall Institute of Medical Research
- Toscana Biomarkers Srl
- University Health Network
- University of Alberta
- University of California Irvine
- University of California San Francisco
- University of Chicago
- University of Colorado
- University of Illinois at Chicago
- University of Maryland Baltimore
- University of Missouri
- University of New South Wales
- University of Oslo
- University of Oxford
- University of Pecs
- US Biomarkers Inc
- Veravas Inc
- VolitionRX Ltd
- Washington University in St Louis
- WerfenLife SA
- XEPTAGEN SpA
- Yale University